MedPage Today on MSN5d
Tezspire Treats Chronic Sinus Symptoms With Nasal PolypsTezepelumab (Tezspire) reduced nasal polyps and symptoms in severe chronic rhinosinusitis while also decreasing need for ...
The prevalence of chronic sinusitis in China is about 8 percent, meaning it affects approximately 107 million people, ...
Treatment with tezepelumab has been effective for sinonasal symptoms in patients with severe, uncontrolled asthma and a ...
In the early 2000s, the actress Priyanka Chopra underwent nose surgery to remove a nasal polyp, but unexpected complications ...
FDA reviews GSK depemokimab for asthma and CRSwNP, with a decision expected by December 2025. Phase 3 data shows improvements ...
The Independent on MSN7d
Asthma drug showed positive results in trials for people with nasal polypsAn asthma drug has shown positive results when used to treat nasal polyps, researchers have said. Tezepelumab was first ...
An international collaboration of researchers, sponsored by GSK and working on behalf of the ANCHOR-1 and ANCHOR-2 trial ...
Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window SAN DIEGO -- Tezepelumab (Tezspire) reduced nasal polyps and symptoms in severe chronic rhinosinusitis while also ...
A global drug trial to test the effectiveness of the asthma drug tezepelumab in treating nasal polyps has shown significant ...
Amgen and AstraZeneca have announced full results from the Phase III, registrational WAYPOINT trial showing that Tezspire ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback